Research brief

Melanotan-2 for Sale — Research-Grade Peptides

Q: How does Melanotan-2 differ from naturally occurring alpha-MSH in melanocortin receptor research?

Melanotan-2 is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH) with two key structural modifications: norleucine substitution at position 4 to prevent oxidative degradation, and cyclization of the core binding sequence to restrict conformational flexibility. These changes increase MC1R binding affinity approximately 1000-fold compared to endogenous α-MSH, with an EC50 in the low nanomolar range. The higher potency allows researchers to conduct dose-response experiments at concentrations low enough to avoid receptor desensitization, a common problem in high-dose α-MSH studies. However, Melanotan-2 also exhibits pan-agonist activity at MC3R, MC4R, and MC5R, requiring careful experimental design to isolate MC1R-specific effects from off-target receptor activation.

Q: Can reconstituted Melanotan-2 be stored at room temperature if refrigeration is temporarily unavailable?

No — reconstituted Melanotan-2 must be stored at 2–8°C and should never be kept at room temperature for more than 30 minutes during active use. Even brief temperature excursions above 8°C initiate oxidative degradation of methionine residues and partial unfolding of the cyclic structure, reducing receptor binding affinity measurably within hours. Studies analyzing peptide stability show that melanocortin analogs stored at 20–25°C lose 15–25% potency within 24 hours due to hydrolysis of peptide bonds and oxidative stress on disulfide bridges. If refrigeration fails, the peptide should be transferred to a laboratory cold room or packed with ice packs immediately — prolonged room temperature exposure renders the solution unreliable for quantitative research.

Q: What is the cost difference between research-grade and commercial-grade Melanotan-2 for sale?

Research-grade Melanotan-2 typically costs 40–60% more than commercial-grade alternatives due to small-batch synthesis, per-batch HPLC and mass spectrometry verification, endotoxin testing, and cold-chain shipping with temperature monitoring. A 10 mg research-grade vial from Real Peptides costs approximately what three commercial-grade vials would cost — but commercial suppliers rarely provide batch-specific purity reports, amino-acid sequencing confirmation, or temperature-documented shipping. The price difference reflects the cost of quality assurance procedures required for reproducible research: HPLC-grade reagents, pharmaceutical-standard synthesis environments, and per-batch verification rather than spot-checking. Researchers should evaluate cost per verified batch rather than cost per milligram — a cheaper peptide with unknown purity introduces experimental variability that exceeds any upfront savings.

Q: What are the most common safety risks when handling Melanotan-2 in laboratory settings?

The primary safety risks are accidental self-injection during reconstitution or dosing, and allergic reactions to benzyl alcohol in bacteriostatic water among sensitive individuals. Melanotan-2 is a potent melanocortin receptor agonist — even microdoses can cause systemic effects including nausea, flushing, and appetite suppression if accidentally injected. Researchers should use needles with safety guards, work in biosafety cabinets when possible, and dispose of sharps in puncture-resistant containers immediately after use. Skin contact with lyophilized powder or reconstituted solution should be avoided; the peptide can be absorbed transdermally in concentrations above 1 mg/mL. Facilities should maintain Safety Data Sheets (SDS) for Melanotan-2 and train personnel on spill containment procedures — peptide spills should be neutralized with dilute acetic acid solution before surface cleaning.

Q: How does Melanotan-2 purity below 98% affect experimental reproducibility in melanocortin receptor assays?

Purity below 98% introduces peptide fragments, synthesis byproducts, and truncated sequences that compete for melanocortin receptor binding sites, creating inconsistent dose-response curves across experiments. Even 5% impurity — seemingly minor — means that a nominal 1 mg dose contains 50 micrograms of contaminants that may include deletion sequences missing critical amino acids, or synthesis intermediates with partial cyclization. These fragments often bind MC receptors with lower affinity but long residence times, acting as partial antagonists that blunt the response to full-length Melanotan-2. Research published in Peptide Science found that receptor binding assays using peptides with 92–95% purity showed 30–40% variability in EC50 measurements compared to ≥98% purity standards — variability large enough to obscure genuine pharmacological differences between experimental conditions.

Q: What is the best method to verify that Melanotan-2 for sale matches the advertised purity and molecular weight?

Request a Certificate of Analysis (COA) with the specific batch number matching your order, showing HPLC purity percentage and mass spectrometry molecular weight confirmation. The COA should include chromatogram data — a visual graph showing the peptide peak and any impurity peaks — not just a summary table. Verify that the molecular weight matches the expected value for Melanotan-2 (1024.2 g/mol for the acetate salt form) within ±0.5 Daltons, and that HPLC purity is ≥98% with impurity peaks individually quantified. Reputable suppliers like Real Peptides publish COAs on their website with searchable batch numbers; suppliers that provide only generic COAs without batch-specific data or refuse to share chromatogram images are likely using template documents rather than testing each batch individually.

Q: How does Melanotan-2 compare to Melanotan-1 for photoprotection research applications?

Melanotan-1 (afamelanotide) is a linear 13-amino-acid analog with higher MC1R selectivity and lower cross-reactivity at MC3R and MC4R compared to Melanotan-2, making it better suited for photoprotection studies where melanogenesis is the sole endpoint of interest. Melanotan-2 has broader melanocortin receptor activity — it binds MC1R, MC3R, MC4R, and MC5R — which introduces confounding variables like appetite suppression (MC4R) and anti-inflammatory effects (MC3R) in animal models. However, Melanotan-2 has a longer half-life and approximately 10-fold greater MC1R potency than Melanotan-1, allowing lower doses and less frequent administration in chronic studies. Researchers studying pure melanogenesis pathways should use [Melanotan 1](https://www.realpeptides.co/products/melanotan-1/) for receptor selectivity; those investigating multi-receptor interactions or metabolic effects should use Melanotan-2.

Q: What documentation should research institutions require when sourcing Melanotan-2 for grant-funded studies?

Grant-funded research requires peptides with full traceability: batch-specific Certificates of Analysis showing HPLC purity ≥98%, mass spectrometry molecular weight confirmation, endotoxin testing results (<0.5 EU/mL for in vivo studies), and cold-chain shipping documentation with temperature monitoring logs. Institutions should also request the supplier's business license, GMP certification if applicable, and a signed Material Safety Data Sheet (MSDS) specific to Melanotan-2. Many grant compliance offices require that peptides used in published research be traceable to a verified supplier with documented quality control — generic suppliers without COA records or batch traceability create compliance issues if study results are later audited or challenged during peer review. Real Peptides provides all required documentation with every order, meeting NIH and NSF grant compliance standards for research reagents.

Q: Why do some Melanotan-2 batches dissolve faster or slower during reconstitution?

Dissolution rate depends on lyophilization quality, particle size distribution, and residual moisture content in the powder — factors controlled during the freeze-drying process after synthesis. Peptides lyophilized with optimal excipients (typically mannitol or trehalose) form fine, uniform particles that dissolve within 2–3 minutes when bacteriostatic water is added gently down the vial side. Poorly lyophilized batches form large aggregates or chunks that take 10–15 minutes to fully dissolve, sometimes requiring gentle agitation. Slow dissolution doesn’t necessarily indicate low purity, but it suggests suboptimal manufacturing processes that may correlate with other quality control gaps. Researchers should avoid shaking or vortexing to speed dissolution — mechanical agitation denatures peptide structure. If a batch takes longer than 10 minutes to dissolve at 2–8°C, contact the supplier for a replacement; prolonged dissolution often indicates moisture absorption during storage, which accelerates peptide degradation.

Q: Can Melanotan-2 for sale be used in combination with other melanocortin receptor ligands in the same experiment?

Yes, but researchers must account for competitive binding and allosteric interactions at melanocortin receptors when designing multi-ligand protocols. Melanotan-2 has high affinity for MC1R, MC3R, and MC4R — adding a second ligand like α-MSH or a selective MC4R antagonist creates competitive inhibition that shifts dose-response curves and changes apparent receptor occupancy. Studies combining Melanotan-2 with other peptides should use receptor binding assays or radioligand displacement experiments to characterize interaction kinetics before proceeding to functional assays. Additionally, peptides should be reconstituted in separate vials and mixed immediately before application — pre-mixing peptides in the same solution can cause aggregation or peptide-peptide interactions that reduce bioavailability. Research institutions exploring combination therapies or receptor subtype selectivity can access verified peptides including [BPC-157](https://www.realpeptides.co/products/bpc-157-peptide/) and other research tools through Real Peptides’ catalog.

Real Peptides Research TeamEditorial

Updated March 26, 202611 min read

59 WORDS

Short answer

Most peptide degradation happens before the research even starts. During synthesis, storage, or shipping. A 2023 study published in the Journal of Pharmaceutical Sciences found that improperly stored synthetic peptides lose up to 40% potency within 72 hours of temperature excursion above 8°C, rendering experimental results unreliable regardless of protocol design. We've worked with research institutions across multiple disciplines.

Key takeaways

Melanotan-2 is a synthetic melanocortin receptor agonist with approximately 1000-fold greater MC1R binding affinity than endogenous α-MSH, used primarily in melanogenesis and photoprotection research.
Small-batch synthesis with per-batch HPLC and mass spectrometry verification ensures amino-acid sequencing accuracy. Large-batch synthesis often skips per-batch verification, introducing sequence variability.
Reconstituted Melanotan-2 must be stored at 2–8°C and used within 28 days; any temperature excursion above 8°C causes irreversible oxidative degradation and partial unfolding of the cyclic structure.
Air injection during reconstitution creates positive pressure that pulls contaminants into the peptide solution during withdrawal. Inject bacteriostatic water without pre-injecting air to prevent backflow contamination.
Research-grade Melanotan-2 for sale includes cold-chain documentation, temperature-monitored shipping, and purity ≥98% verified by HPLC. Commercial-grade suppliers rarely provide verification or temperature guarantees.
Real Peptides synthesizes Melanotan-2 in small batches with exact amino-acid sequencing, ensuring reproducible results across experimental cycles and eliminating batch-to-batch variability.

We've worked with research institutions across multiple disciplines. The gap between reliable peptide suppliers and the rest comes down to three things most catalogs never mention: synthesis batch size, amino-acid sequencing verification, and cold-chain integrity from production to delivery.

What is Melanotan-2 for sale used for in research settings?

Melanotan-2 for sale through research-grade suppliers is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) used primarily in melanogenesis studies, photoprotection research, and investigations into melanocortin receptor pathways. The peptide consists of a seven-amino-acid sequence (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) with significantly higher receptor affinity than endogenous α-MSH, making it a valuable tool for controlled melanocortin pathway studies.

Yes, Melanotan-2 for sale at Real Peptides is designed for biological research. But understanding what separates research-grade peptides from lower-quality alternatives requires more than reading a product description. The peptide's stability depends entirely on synthesis precision and post-production handling. This article covers exactly how amino-acid sequencing affects receptor binding reliability, what purity thresholds mean for reproducible results, and what preparation mistakes negate experimental validity entirely.

Why Amino-Acid Sequencing Precision Determines Melanotan-2 Research Reliability

The cyclic structure of Melanotan-2. Specifically the disulfide bridge between cysteine residues at positions 4 and 10 in the original α-MSH sequence. Is what gives the peptide its melanocortin receptor selectivity. Even a single amino-acid substitution or incomplete cyclization during synthesis changes binding affinity enough to produce inconsistent experimental outcomes. Research published in the European Journal of Medicinal Chemistry demonstrated that Melanotan-2 analogs with D-Phe replaced by L-Phe showed 60% reduced MC1R binding affinity, fundamentally altering melanogenesis pathway activation.

Small-batch synthesis allows for per-batch amino-acid sequencing verification using high-performance liquid chromatography (HPLC) and mass spectrometry. Techniques that confirm each residue appears in the correct position with the intended stereochemistry. Large-batch commercial synthesis often skips per-batch verification, relying instead on spot-checking or certificate of analysis (COA) templates that reference earlier production runs rather than the specific batch being shipped.

Real Peptides uses small-batch synthesis exclusively. Every Melanotan-2 for sale batch undergoes HPLC purity analysis and mass spectrometry confirmation before packaging. The result: researchers receive peptides with verified sequence fidelity, eliminating one of the most common sources of inter-experiment variability. When studying melanocortin receptor subtypes. MC1R, MC3R, MC4R, MC5R. Receptor selectivity depends entirely on precise tertiary structure, which depends entirely on exact amino-acid sequence. A supplier that can't verify sequencing per-batch can't guarantee reproducibility.

Temperature stability is the second factor most researchers underestimate. Lyophilized Melanotan-2 remains stable at −20°C for 24 months, but once reconstituted with bacteriostatic water, the peptide must be refrigerated at 2–8°C and used within 28 days. Any excursion above 8°C. Even for six hours. Initiates oxidative degradation of methionine residues and partial unfolding of the cyclic structure. We've reviewed stability data across peptide classes; melanocortin analogs are particularly sensitive to oxidative stress because the cyclic constraint increases strain on disulfide bonds under elevated temperatures.

Researchers working with Melanotan-2 for sale should request cold-chain documentation showing uninterrupted refrigeration from synthesis to delivery. Real Peptides ships all peptides in insulated packaging with temperature-monitoring indicators. If the indicator shows temperature excursion, the batch is replaced at no cost. That policy exists because a peptide that reached 15°C during transit isn't just less effective; it's structurally compromised in ways HPLC can't always detect post-thaw.

Receptor Binding Pharmacology: What Makes Melanotan-2 Distinct in Melanocortin Research

Melanotan-2 binds to melanocortin receptors MC1R, MC3R, MC4R, and MC5R with varying affinities. This pan-agonist activity is both the peptide's primary research value and the reason experimental design must account for off-target effects. MC1R activation drives eumelanin synthesis in melanocytes, the pathway most photoprotection studies target. MC4R activation in the hypothalamus modulates appetite and energy expenditure, making Melanotan-2 a tool in metabolic research despite its original design as a tanning agent analog.

Binding affinity measured in vitro shows Melanotan-2 has approximately 1000-fold greater potency at MC1R than endogenous α-MSH, with a half-maximal effective concentration (EC50) in the low nanomolar range. That potency increase comes from two structural modifications: replacement of methionine at position 4 with norleucine (Nle), which prevents oxidative degradation, and cyclization of the core binding sequence, which restricts conformational flexibility and increases receptor residence time.

Researchers studying melanogenesis pathways use Melanotan-2 because its supraphysiological potency allows dose-response experiments at concentrations low enough to avoid receptor desensitization. A problem with high-dose α-MSH studies. The downside: MC4R cross-reactivity means appetite suppression and nausea can appear as confounding variables in animal models, requiring careful control group design and dose titration to isolate MC1R-specific effects.

One mechanism most research protocols miss: Melanotan-2's half-life in reconstituted solution is significantly shorter than its lyophilized shelf life. Once mixed with bacteriostatic water, the peptide undergoes slow hydrolysis of peptide bonds, particularly at the C-terminus, reducing receptor binding affinity over time even when stored correctly at 2–8°C. Studies using reconstituted Melanotan-2 beyond 21 days post-mixing show measurable potency loss in MC1R binding assays. Not because of microbial contamination, but because of chemical degradation of the peptide backbone itself.

Real Peptides provides dosing guidance based on intended application: photoprotection studies typically use 0.5–1.0 mg per dose in animal models, while melanocortin receptor binding assays require low-nanomolar concentrations (10–50 nM) to avoid receptor saturation. Researchers should calculate total peptide need per experimental cycle and reconstitute only what will be used within 14 days. Multiple small vials outperform one large vial when experimental timelines extend beyond three weeks.

Storage, Reconstitution, and Handling Protocols That Preserve Peptide Integrity

The most common error in Melanotan-2 research isn't contamination. It's air injection during reconstitution. When researchers inject bacteriostatic water into a lyophilized vial, they often inject an equivalent volume of air first to equalize pressure. That air creates positive pressure inside the vial, which forces solution back through the needle during withdrawal, pulling airborne particulates and potential contaminants into the peptide solution. Over multiple withdrawals, this contamination risk compounds.

Correct reconstitution protocol: inject bacteriostatic water slowly down the side of the vial without injecting air first. Allow the lyophilized powder to dissolve passively. Do not shake or vortex, as mechanical agitation can denature the cyclic structure. The vial will have slight negative pressure after water addition; this is intentional and prevents backflow contamination. When drawing solution for experiments, insert the needle, invert the vial, and allow atmospheric pressure to equalize naturally as solution is withdrawn.

Storage temperature for unreconstituted Melanotan-2 for sale is −20°C, with acceptable short-term storage at 2–8°C for up to 30 days. Once reconstituted, refrigerate at 2–8°C and never freeze. Freeze-thaw cycles cause ice crystal formation that physically disrupts peptide structure. Researchers working in facilities without dedicated peptide refrigerators should use a laboratory refrigerator with temperature logging, not a shared break room unit that experiences frequent door openings and temperature fluctuations.

Light exposure degrades Melanotan-2 through photochemical oxidation of tryptophan and histidine residues in the binding sequence. Store reconstituted vials in amber glass or wrap clear vials in aluminum foil. Even brief exposure to direct sunlight. 15 minutes on a laboratory bench near a window. Measurably reduces peptide potency in UV-Vis spectroscopy assays.

Bacteriostatic water is the preferred reconstitution solvent because the 0.9% benzyl alcohol preservative inhibits bacterial growth in multi-use vials. Sterile water for injection (SWFI) is an alternative for single-use applications, but it lacks antimicrobial activity and must be used within 24 hours of reconstitution. Researchers should never use saline for reconstitution. The ionic strength of sodium chloride accelerates peptide aggregation in concentrated solutions, creating visible precipitates that indicate irreversible denaturation.

Real Peptides includes Bacteriostatic Water with every peptide order, eliminating the need to source pharmaceutical-grade reconstitution solvent separately. The water is USP-grade, sterile-filtered to 0.22 microns, and tested for endotoxin levels below 0.5 EU/mL. The threshold required for in vivo research applications.

Melanotan-2 for Sale: Research-Grade vs Commercial-Grade Comparison

Not all Melanotan-2 for sale is synthesized or verified to the same standards. The table below compares research-grade peptides from Real Peptides against typical commercial-grade suppliers.

Feature	Research-Grade (Real Peptides)	Commercial-Grade Suppliers	Professional Assessment
Synthesis Method	Small-batch solid-phase peptide synthesis (SPPS) with per-batch HPLC verification	Large-batch synthesis with spot-check QC or COA templates from prior batches	Small-batch synthesis allows sequencing verification per batch. Large-batch relies on statistical sampling
Purity Verification	HPLC purity ≥98%, mass spectrometry confirmation of molecular weight, endotoxin testing <0.5 EU/mL	Variable. Often 90–95% purity with no mass spec verification or endotoxin testing	Purity below 98% introduces peptide fragments and synthesis byproducts that interfere with receptor binding assays
Cold-Chain Documentation	Temperature-monitored shipping with replacement guarantee if excursion detected	Standard shipping with no temperature monitoring or replacement policy	Temperature excursion above 8°C denatures peptides irreversibly. Documentation proves integrity
Reconstitution Guidance	Detailed protocol including solvent type, injection technique, storage duration, and light protection	Generic instructions or none provided	Improper reconstitution is the leading cause of experimental variability in peptide research
Intended Application	Biological research, melanocortin receptor studies, photoprotection assays, peptide pharmacology	Cosmetic or unverified use with inconsistent batch quality	Research-grade peptides are synthesized and tested to lab reliability standards. Commercial-grade are not
Shelf Life Documentation	24 months at −20°C unreconstituted, 28 days at 2–8°C post-reconstitution with expiration dates on labels	Often no expiration date or shelf-life guidance provided	Peptides without expiration dates create compliance and reproducibility issues in regulated research

What If: Melanotan-2 Research Scenarios

What If the Reconstituted Melanotan-2 Develops Visible Particulates or Cloudiness?

Discard the solution immediately. Visible particulates indicate peptide aggregation or microbial contamination, both of which render the peptide unusable for research. Aggregation occurs when peptides misfold and clump together, often due to freeze-thaw cycles, prolonged storage beyond 28 days, or reconstitution with incorrect solvent like saline. Cloudiness that doesn't clear after gentle swirling suggests bacterial growth if bacteriostatic water wasn't used, or peptide precipitation if the solution pH shifted outside the stability range of 4.0–7.0. Do not attempt to filter or salvage cloudy peptide solutions. The structural damage is irreversible and will produce unreliable experimental results.

What If the Lyophilized Melanotan-2 Was Shipped Without Temperature Monitoring?

Request a replacement batch with documented cold-chain integrity before beginning experiments. Peptides exposed to temperatures above 25°C during shipping undergo partial denaturation that HPLC purity reports from the original synthesis won't detect. The damage occurs post-production. Real Peptides includes temperature indicators with every shipment; if the indicator shows excursion, the batch is replaced at no cost because there's no reliable way to quantify potency loss from heat exposure without conducting full receptor binding assays. Starting research with thermally compromised peptides introduces systematic error that invalidates dose-response data and makes cross-study comparisons impossible.

What If the Research Protocol Requires Melanotan-2 Concentrations Higher Than the Reconstituted Solution Provides?

Never concentrate peptide solutions by evaporation or lyophilization after reconstitution. Both methods denature the cyclic structure and create aggregates. Instead, reconstitute the lyophilized powder with a smaller volume of bacteriostatic water to achieve higher molarity. For example, if the standard protocol uses 2 mL to reconstitute a 10 mg vial (yielding 5 mg/mL), using 1 mL instead yields 10 mg/mL. Ensure the peptide fully dissolves at the higher concentration. Some peptides have solubility limits that cause precipitation above specific molarities. If precipitation occurs, dilute incrementally with additional bacteriostatic water until the solution clears, then adjust dosing volumes accordingly.

What If Multiple Researchers Need Access to the Same Melanotan-2 Vial Over Several Weeks?

Aliquot the reconstituted solution into sterile cryovials within 48 hours of reconstitution, then store aliquots at −80°C for single-use applications. Repeated needle insertions into a multi-use vial increase contamination risk and introduce air each time, degrading the remaining peptide. Frozen aliquots at −80°C remain stable for 3–6 months without the degradation seen in refrigerated multi-use vials beyond 28 days. Thaw each aliquot at 2–8°C immediately before use. Never thaw at room temperature or in a water bath, as rapid temperature change causes condensation inside the vial that dilutes the peptide and introduces contamination risk.

The Unfiltered Truth About Melanotan-2 for Sale in Research Contexts

Here's the honest answer: most Melanotan-2 for sale online isn't synthesized for laboratory research. It's produced for cosmetic markets with minimal quality control and no batch verification. The difference isn't just labeling. Research-grade synthesis requires per-batch amino-acid sequencing, HPLC purity analysis, mass spectrometry molecular weight confirmation, and endotoxin testing. Procedures that cost significantly more than large-batch synthesis with spot-check quality control. Suppliers that don't publish purity reports with specific batch numbers are selling peptides with unknown sequence fidelity and unknown contamination levels.

The gap matters because melanocortin receptor research depends on exact peptide structure. A single substitution. D-Phe replaced with L-Phe, or incomplete cyclization during synthesis. Changes receptor binding kinetics enough to make dose-response curves unreliable. Researchers using unverified peptides aren't just risking experimental failure; they're introducing systematic error that makes their data incomparable to published studies using verified reference standards.

Real Peptides exists because that quality gap was creating reproducibility problems across research institutions. Small-batch synthesis costs more per milligram, but it's the only method that guarantees sequencing accuracy and allows cold-chain documentation from synthesis to delivery. When you source Melanotan-2 for sale from Real Peptides, you're not paying for packaging. You're paying for verifiable peptide integrity that makes your experimental results defensible.

If a supplier's price is 40% below market average and they don't publish batch-specific purity reports, the peptide wasn't synthesized to research standards. The economics don't support it. Quality peptide synthesis requires expensive reagents, HPLC-grade solvents, and per-batch verification. Cutting any of those steps reduces cost but destroys reliability. The question isn't whether to pay more for research-grade peptides; it's whether your experimental timeline can absorb the cost of repeating failed studies using degraded or missequenced peptides.

Melanotan-2 research requires the same peptide quality standards as any other melanocortin receptor study. If the supplier can't verify sequence, purity, and cold-chain integrity with documentation, the peptide isn't research-grade regardless of what the product page claims. Real Peptides provides that documentation because reproducibility depends on it. And reproducibility is the only metric that matters when experimental results need to withstand peer review.

If your research depends on precise melanocortin receptor binding or photoprotection pathway studies, the peptide you choose determines whether your data holds up under scrutiny. Real Peptides synthesizes every batch with the same standards we'd expect if we were running the experiments ourselves. Exact sequencing, verified purity, and documented cold-chain from production to your lab. That's not marketing language; it's the minimum standard for research that needs to be reproducible six months or six years from now.

Questions